Sex Differences in Progesterone Effects on Responses to Stress and Drug Cues
NCT00585520 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2014-02-12
Summary
Cocaine dependence is a chronic, relapsing disorder in which stress/negative mood and exposure to drug-related stimuli or "cues" are associated with high rates of relapse (McKay et al., 1995; O'Brien et al., 1998; R. Sinha, 2001; Shaham et al., 2003). In particular, sex differences in relapse precipitants have been noted, with women reporting greater stress related relapses while men report higher number of relapses associated with drug cue/temptation situations (Lex, 1991; McKay et al., 1996; R. Sinha, 2001; R. Sinha, Rounsaville BJ, 2002). Current SCOR studies have shown that stress and cocaine cues increase drug craving and stress related arousal, responses that differ in cocaine men and women (R. Sinha et al., 2003; H.C. Fox et al., 2005a). Furthermore, stress-induced cocaine craving and HPA responses are predictive of cocaine relapse, which is also moderated by gender (R. Sinha et al., 2006). However, no previous research has examined the basis of sex differences in stress and cue induced craving and arousal, both of which are known to increase relapse susceptibility. Greater knowledge of the sex-specific neurobiology of cocaine dependence will facilitate development of gender-specific cocaine relapse prevention efforts.
Growing evidence supports a role for gonadal hormones in explaining the sex differences observed in stress responses as well as in the behavioral responses to cocaine (Festa \& Quinones-Jenab, 2004; K. Carroll, Fenton LR, Ball SA, Nich C, Frankforter TL, Shi J, Rounsaville BJ, 2004; Lynch, 2006; Kajanti \& Phillips, 2006). Estrogen increases behavioral responses to cocaine, while presence of progesterone decreases subjective and behavioral effects of cocaine, more so in females than males (Jackson et al., 2006; Sofuogu et al., 1999; M. Sofuoglu et al., 2002; Evans \& Foltin, 2006). Stress and cocaine each enhance brain stress circuits, namely the corticotrophin releasing factor (CRF)-hypothalamic-pituitary-adrenal (HPA) axis and central noradrenergic/sympatho-adrenomedullary (SAM) pathways and both activate the mesolimbic dopaminergic systems involved in the rewarding effects of cocaine (ADD REFS). Exposure to Stress, cocaine or cocaine cues will each increase cocaine craving and HPA axis responses. Importantly, progesterone which affects behavioral responses to cocaine, also plays a key role in stress regulation. However, it is not known whether progesterone alters stress-induced and drug cue-induced craving and related stress arousal, markers that predict cocaine relapse outcomes. Our preliminary data suggest that women exposed to stress and to drug cues in the laboratory during the luteal phase (high progesterone) show lower stress induced and drug cue-induced craving, anxiety and cortisol responses compared to those in the late follicular phase (high estrogen) (see preliminary Studies section CX). On the basis of this previous research, we propose a double-blind placebo controlled study of to examine progesterone's effects on stress and cue-related responses in cocaine dependent men and women. We hypothesize that high dose of progesterone (200 mg bid) vs. placebo will alter stress-induced cocaine craving, negative affect, physiological and HPA responses to stress, and these changes will be greater in women than men.
Conditions
- Cocaine Dependence
Interventions
- DRUG
-
Progesterone
200mg BID for 5 days
- DRUG
-
Placebo
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
collaborator NIH -
Yale University
lead OTHER
Principal Investigators
-
Rajita Sinha, PhD · Yale University
Study Design
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-09-30
- Primary Completion
- 2013-09-30
- Completion
- 2013-09-30
Countries
- United States
Study Locations
More Related Trials
-
The Role of Neuroactive Steroids in Stress, Drug Craving and Drug Use in Cocaine Use Disorders
NCT03953612 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Investigation of Intranasal Oxytocin on Relapse Risk in Cocaine-dependent Patients.
NCT02255357 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Oxytocin in Cocaine Dependence
NCT01573273 ·Status: COMPLETED ·Phase: NA
-
Establishing and Eliminating Cue-drug Associations in Human Cocaine Addiction
NCT01978457 ·Status: TERMINATED ·Phase: PHASE1
-
Gender and Neural Substrates of Stress and Craving
NCT00756925 ·Status: COMPLETED
-
Pathophysiological Subtyping of Abnormalities in Cocaine Dependence - 9
NCT00015275 ·Status: COMPLETED ·Phase: PHASE4
-
A Sequenced Behavioral and Medication Intervention for Cocaine Dependence
NCT01986075 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Progesterone and Atomoxetine for Cocaine Cessation
NCT01741376 ·Status: WITHDRAWN ·Phase: NA
-
Automatic Versus Evaluative Components of Cue Reactivity
NCT01036126 ·Status: COMPLETED
-
Serotonin/Dopamine Antagonism of Cocaine Effect: 1 - 1
NCT00000309 ·Status: TERMINATED ·Phase: PHASE2
-
Stress Hormones and Human Cocaine Use - 7
NCT00000290 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of Potential Interactions Between Cocaine and RPR 102681 - 1
NCT00067535 ·Status: COMPLETED ·Phase: PHASE1
-
Serotonin/Dopamine Antagonism of Cocaine Effect: 2 - 2
NCT00000310 ·Status: TERMINATED ·Phase: PHASE2
-
Extending Long-term Outcomes Through an Adaptive Aftercare Intervention
NCT02143063 ·Status: COMPLETED ·Phase: NA
-
Reinforcing Effects of Cocaine During Phendimetrazine Maintenance
NCT02522325 ·Status: COMPLETED ·Phase: PHASE1
-
Brain Changes in Stimulant Dependent Subjects - 8
NCT00000343 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Nefazodone on Treatment of Female Cocaine Abusers - 3
NCT00000286 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacogenetics of Disulfiram for Cocaine
NCT00149630 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of Extended Treatments for Drug Dependence
NCT00685659 ·Status: COMPLETED ·Phase: NA
-
Behavioral Treatment for Cocaine Dependent Women
NCT00914381 ·Status: COMPLETED ·Phase: PHASE2
-
Cocaine Cue-reactivity Incubation Study
NCT07091877 ·Status: RECRUITING ·Phase: NA
-
Effects of Propranolol on Responses to Drug-Related Imagery Scripts
NCT00688805 ·Status: TERMINATED ·Phase: PHASE1
-
Neural Substrates of Emotion: Impact of Cocaine Dependence
NCT02682784 ·Status: COMPLETED ·Phase: PHASE2
-
Cocaine Use Reduction and Health
NCT03224546 ·Status: COMPLETED ·Phase: NA
-
Glutamatergic Modulation to Facilitate the Behavioral Treatment of Cocaine Use Disorders
NCT03344419 ·Status: SUSPENDED ·Phase: PHASE3